المؤلفون: De Castro G., Cho, Byoung Chul, Kudaba I., Wu Y.-L., Lopes G., Kowalski D.M., Turna H.Z.

مصطلحات موضوعية: anaplastic lymphoma kinase, carboplatin, epidermal growth factor, paclitaxel, pembrolizumab, pemetrexed, programmed death 1 ligand 1, antineoplastic agent, CD274 protein, human, epidermal growth factor receptor, protein tyrosine kinase, adult, advanced cancer, adverse drug reaction, aged, alopecia, anemia, area under the curve, Article, brain metastasis, cancer chemotherapy, cancer combination chemotherapy, cancer patient, cancer radiotherapy, clinical outcome, comparative study, constipation, current smoker, death

وصف الملف: application/pdf

العلاقة: Journal of Clinical Oncology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.1200/JCO.21.02885Test; https://hdl.handle.net/20.500.12831/12965Test; 41; 11; 1986; 1991; WOS:001037306300010; 2-s2.0-85152165284

الإتاحة: https://doi.org/10.1200/JCO.21.02885Test
https://doi.org/20.500.12831/12965Test
https://hdl.handle.net/20.500.12831/12965Test

المؤلفون: Gadgeel, Shirish M, Rodríguez-Abreu, D., Halmos, B., Garassino, M. C, Kurata, T., Cheng, Y., Jensen, E., Shamoun, M., Rajagopalan, K., Paz-Ares, L.

المصدر: Hematology/Oncology Meeting Abstracts

مصطلحات موضوعية: carboplatin, cisplatin, endogenous compound, epidermal growth factor receptor, paclitaxel, pembrolizumab, pemetrexed, placebo, programmed death 1 ligand 1, unclassified drug, adult, cancer chemotherapy, cancer patient, cancer survival, China, clinical trial, conference abstract, controlled study, drug safety, drug therapy, female, first-line treatment, follow up, gene expression, health care quality, histology, histopathology, human, human tissue, Japan

العلاقة: https://scholarlycommons.henryford.com/hematologyoncology_mtgabstracts/162Test; http://sfxhosted.exlibrisgroup.com/hfhs?sid=EMBASE&issn=15561380&id=doi:10.1016%2Fj.jtho.2023.09.078&atitle=OA14.05+5-Year+Survival+ofTest+Pembrolizumab+Plus+Chemotherapy+for+Metastatic+NSCLC+With+PD-L1+Tumor+Proportion+Score+%3C1%25&stitle=J.+Thorac.+Oncol.&title=Journal+of+Thoracic+Oncology&volume=18&issue=11&spage=S77&epage=S78&aulast=Gadgeel&aufirst=S.&auinit=S.&aufull=Gadgeel+S.&coden=&isbn=&pages=S77-S78&date=2023&auinit1=S&auinitm=

الإتاحة: https://scholarlycommons.henryford.com/hematologyoncology_mtgabstracts/162Test

المؤلفون: Isamu Okamoto, Tatsuo Ohira, Nobuyuki Yamamoto, Hidehito Horinouchi, Toyoaki Hida, Shinji Atagi, Tatsuro Fukuhara, Miyako Satouchi, Kazuma Kishi, Shunichi Sugawara, Shi Rong Han, Hideo Saka, Victoria Ebiana, Katsuyuki Hotta, Keisuke Aoe, Kazuhiko Nakagawa, Hiroshi Sakai, Hiroaki Okamoto, Kazuo Noguchi, Kaname Nosaki, Atsushi Horiike, Shigeki Umemura, Toshiaki Takahashi, Takayasu Kurata, Nobuyuki Katakami, Akimasa Sekine

المصدر: Cancer Science
Cancer Sci

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, Lung Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, non‐small‐cell lung carcinoma, Pembrolizumab, Kaplan-Meier Estimate, Gastroenterology, Deoxycytidine, B7-H1 Antigen, Carboplatin, 0302 clinical medicine, Antineoplastic Agents, Immunological, Japan, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Anaplastic Lymphoma Kinase, Neoplasm Metastasis, Aged, 80 and over, Cross-Over Studies, Hazard ratio, General Medicine, Middle Aged, PD-L1 protein, Progression-Free Survival, Oncology, 030220 oncology & carcinogenesis, non-small-cell lung carcinoma, Carcinoma, Squamous Cell, Female, Original Article, Non small cell, pembrolizumab, Adult, medicine.medical_specialty, Paclitaxel, First line, Pemetrexed, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, 03 medical and health sciences, Drug Therapy, Clinical Research, Internal medicine, medicine, Confidence Intervals, Humans, Lung cancer, Adverse effect, PD‐L1 protein, Aged, Chemotherapy, business.industry, Genes, erbB-1, Original Articles, medicine.disease, Survival Analysis, Gemcitabine, Confidence interval, Retraction, 030104 developmental biology, treatment outcome, Cisplatin, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4692f872031566a6ba7ec9528f7d1191Test
https://doi.org/10.1111/cas.15144Test

المؤلفون: Taichi Miyawaki, Kazuhiko Nakagawa, Kazushige Wakuda, Tamio Okimoto, Kentaro Ito, Hideyuki Harada, Hirotsugu Kenmotsu, Yasutaka Chiba, Takehiro Uemura, Shinya Sakata, Koji Haratani, Yasuhisa Ohde, Tomohiro Sakamoto, Nobuyuki Yamamoto, Yasumasa Nishimura, Yoshihito Kogure

المصدر: BMC Cancer, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Cancer

مصطلحات موضوعية: Adult, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Paclitaxel, Phases of clinical research, Pemetrexed, Pembrolizumab, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, Carboplatin, Maintenance Chemotherapy, Study Protocol, Antineoplastic Agents, Immunological, Japan, Maintenance therapy, Albumins, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Genetics, Clinical endpoint, Humans, Medicine, Oligometastatic disease, Progression-free survival, Lung cancer, Local ablative therapy, Immune Checkpoint Inhibitors, RC254-282, Aged, business.industry, Standard treatment, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Induction Chemotherapy, Middle Aged, medicine.disease, Programmed cell death 1 inhibitor, Clinical trial, Carcinoma, Squamous Cell, Cisplatin, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f72a57f7fcff041b8f32ec9c83d45b4Test
https://doaj.org/article/39dfc6480ce2459281803dd7cfc8bd88Test

المؤلفون: Yi‐Long Wu, Li Zhang, Yun Fan, JianYing Zhou, Qing Zhou, Wei Li, ChengPing Hu, GongYan Chen, Xin Zhang, CaiCun Zhou, Thao Dang, Sara Sadowski, Debra A. Kush, Yu Zhou, Ben Li, Tony Mok

المصدر: International Journal of Cancer

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, China, Lung Neoplasms, non–small‐cell lung cancer, medicine.medical_treatment, Short Report, Pembrolizumab, chemotherapy, Antibodies, Monoclonal, Humanized, PD-L1 Positive, law.invention, 03 medical and health sciences, chemistry.chemical_compound, Young Adult, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Lung cancer, Cancer Therapy and Prevention, Aged, Chemotherapy, business.industry, Hazard ratio, Middle Aged, medicine.disease, Carboplatin, Pemetrexed, chemistry, programmed death ligand 1, 030220 oncology & carcinogenesis, Female, pembrolizumab, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d738eb6422851bd45d601d057c69c71bTest
http://europepmc.org/articles/PMC8048589Test

المؤلفون: Gadgeel, Shirish, Grey, Jhanelle, Rizzo, Maria Teresa, Peterson, Patrick, Kim, Jongseok, Rodríguez-Abreu, Delvys

المصدر: Hematology/Oncology Meeting Abstracts

مصطلحات موضوعية: endogenous compound, pembrolizumab, pemetrexed, placebo, programmed death 1 ligand 1, adult, cancer patient, cancer size, clinical trial, conference abstract, controlled study, distant metastasis, drug efficacy, drug therapy, female, gene expression, health care quality, human, major clinical study, male, non small cell lung cancer, organ systems, protein expression, randomized controlled trial, vascular guide wire, Hematology

العلاقة: https://scholarlycommons.henryford.com/hematologyoncology_mtgabstracts/138Test; http://sfxhosted.exlibrisgroup.com/hfhs?sid=EMBASE&issn=15387445&id=doi:10.1158%2F1538-7445.AM2021-442&atitleTest=Pemetrexed+and+platinum+plus+pembrolizumab+in+patients+with+metastatic+non-squamous+non-small+cell+lung+cancer+by+tumor+burden+at+baseline%3A+A+post-hoc+efficacy+analysis+of+KEYNOTE-189&stitle=Cancer+Res.&title=Cancer+Research&volume=81&issue=13+SUPPL&spage=&epage=&aulast=Gadgeel&aufirst=Shirish&auinit=S.&aufull=Gadgeel+S.&coden=&isbn=&pages=-&date=2021&auinit1=S&auinitm=

الإتاحة: https://scholarlycommons.henryford.com/hematologyoncology_mtgabstracts/138Test

المؤلفون: Kazuo Noguchi, Takayasu Kurata, Takeshi Sawada, Kazuhiko Nakagawa, Shirong Han, Masae Homma, Takashi Seto, Naoyuki Nogami, Miyako Satouchi

المصدر: Cancer Treatment and Research Communications, Vol 29, Iss, Pp 100458-(2021)

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Pembrolizumab, Antibodies, Monoclonal, Humanized, Gastroenterology, chemistry.chemical_compound, Japan, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic agents, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, Programmed death ligand 1, Lung cancer, RC254-282, Pneumonitis, Aged, Chemotherapy, business.industry, Area under the curve, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, medicine.disease, Carboplatin, Non–small-cell lung carcinoma, Pemetrexed, Oncology, chemistry, Female, business, Antitumor activity, Febrile neutropenia, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::851a9bed22ae2704c3eff5cad6b26447Test
https://pubmed.ncbi.nlm.nih.gov/34607222Test

المؤلفون: Delvys Rodriguez-Abreu, Bilal Piperdi, Luis Paz-Ares, Jianxin Lin, Takayasu Kurata, Shirish M. Gadgeel, Balazs Halmos, Baerin Houghton, Marina Chiara Garassino, Ying Cheng, M. Catherine Pietanza, Hossein Borghaei, Corey J. Langer

المصدر: Cancer

مصطلحات موضوعية: Oncology, Adult, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Pembrolizumab, Antibodies, Monoclonal, Humanized, B7-H1 Antigen, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Antineoplastic Agents, Immunological, non–small cell lung cancer, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, antineoplastic agents, Humans, 030212 general & internal medicine, Lung cancer, Aged, Randomized Controlled Trials as Topic, Aged, 80 and over, Chemotherapy, business.industry, Hazard ratio, Cancer, Original Articles, Middle Aged, medicine.disease, Carboplatin, combined drug therapy, programmed cell death ligand 1 protein (human CD274 protein), Pemetrexed, chemistry, Response Evaluation Criteria in Solid Tumors, Chest and Lung Disease, 030220 oncology & carcinogenesis, Original Article, pembrolizumab, Disease Site, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da398adb2787fa3bcc2db943dfc67e66Test
https://pubmed.ncbi.nlm.nih.gov/32914866Test